Apoquel (oclacitinib) is generally well tolerated by most dogs, but it does carry real side effects ranging from mild digestive upset to more serious concerns like increased infection risk and tumor development. Because it works by dialing down part of the immune system, the trade-off for itch relief is reduced immune surveillance, and that’s worth understanding before your dog starts treatment.
How Apoquel Works in Your Dog’s Body
Apoquel targets a specific enzyme called JAK1, which acts as a signaling switch for several immune chemicals that drive allergic itch and inflammation. By blocking JAK1, the drug reduces the activity of multiple inflammatory signals, including the one most directly responsible for the sensation of itch in dogs. It starts working fast, often reducing scratching within one to three hours of the first dose.
The selectivity matters for side effects. Apoquel largely leaves alone the immune signals responsible for making red blood cells and certain other housekeeping functions. But JAK1 also plays a role in the body’s defense against infections and abnormal cell growth, which is why suppressing it creates a specific set of risks.
Common, Mild Side Effects
The most frequently reported side effects are gastrointestinal: vomiting, diarrhea, and decreased appetite. In clinical trials, these occurred at a slightly higher rate in dogs taking Apoquel compared to dogs receiving no treatment. Lethargy has also been noted. For most dogs, these effects are mild and often resolve on their own within the first few days or weeks of treatment.
Compared to cyclosporine, another common allergy medication for dogs, Apoquel actually causes fewer stomach problems. In one head-to-head clinical trial, the cyclosporine group had three times as many gastrointestinal side effects, and six dogs on cyclosporine had to be pulled from the study because of vomiting, versus just one dog on Apoquel. So while digestive upset is possible, it’s less of an issue with this drug than with some alternatives.
Increased Risk of Infections
This is one of the more important side effects to understand. Because Apoquel partially suppresses immune function, dogs on the drug may be more vulnerable to bacterial, fungal, and parasitic infections. The FDA label specifically warns that Apoquel may increase susceptibility to infections, including demodicosis, a skin condition caused by Demodex mites that a healthy immune system normally keeps in check.
Dogs that already have a serious infection should not be started on Apoquel. If your dog develops new skin lesions, ear infections, urinary tract infections, or respiratory infections while on the medication, your vet needs to know. These aren’t reasons to panic, but they do require attention, because the immune suppression that controls your dog’s itching also makes it harder for the body to fight off invaders on its own.
Tumor Development Concerns
The FDA label states that new tumors, both benign and malignant, were observed in dogs taking Apoquel during clinical studies and have continued to be reported after the drug reached the market. This doesn’t necessarily mean Apoquel caused the tumors. Dogs with chronic allergic skin disease tend to be older breeds already prone to cancer, making it difficult to separate the drug’s effect from the baseline risk.
Still, the warning is specific: Apoquel may worsen existing cancerous conditions. Dogs with a history of cancer should be carefully evaluated before starting treatment. Your vet will weigh whether the benefits of itch control justify the theoretical risk of reduced immune surveillance against abnormal cells. For dogs with no cancer history, the risk appears low, but monitoring matters.
Who Shouldn’t Take Apoquel
Apoquel is not approved for dogs under 12 months of age or weighing less than 3 kilograms (about 6.6 pounds). Young dogs have developing immune systems, and suppressing JAK1 signaling during that window could interfere with normal immune development. The safety of Apoquel in breeding, pregnant, or lactating dogs has not been established, so it’s typically avoided in those situations.
Dogs with a history of recurrent serious infections, recurring demodicosis, or cancer need a careful risk-benefit discussion with a veterinarian before starting. The drug can be used alongside many common medications, including NSAIDs, antibiotics, vaccines, and allergy shots, which gives vets flexibility in treatment plans.
What Monitoring Your Dog Needs
If your dog is going to take Apoquel long term, regular blood work is important. The University of Wisconsin Veterinary Care recommends a blood count at two months, six months, and one year after starting treatment. For dogs staying on the medication beyond that first year, an annual checkup should include a physical exam, blood count, kidney and liver panels, and a urine test.
This monitoring catches early signs of problems like low white blood cell counts, which could signal too much immune suppression, or changes in organ function. Most dogs on Apoquel have completely normal blood work year after year, but the monitoring acts as a safety net. If your vet isn’t recommending periodic lab work for a dog on chronic Apoquel therapy, it’s worth asking about.
Putting the Risks in Perspective
Every allergy medication for dogs involves trade-offs. Long-term steroids like prednisone carry risks of diabetes, muscle wasting, and adrenal problems. Cyclosporine causes more stomach upset and can also suppress immune function. Apoquel’s advantage is its speed (relief within hours rather than days or weeks) and its relatively targeted mechanism. Its disadvantage is the immune suppression that comes with blocking JAK1.
For most dogs with moderate to severe allergic dermatitis, the side effect profile of Apoquel is manageable. The mild gastrointestinal effects tend to be temporary. The infection and tumor risks are real but appear to be uncommon, especially with appropriate monitoring. The dogs most likely to have problems are those already dealing with compromised immunity, active infections, or a cancer diagnosis. For an otherwise healthy dog that’s miserable with itching, Apoquel often represents a significant improvement in quality of life with an acceptable level of risk.